A small molecule known as mir-494-3p might play a protective role in the survival of motor nerve cells, a discovery…
Iqra Mumal, MSc
Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Iqra Mumal, MSc
FUS — a protein mutated in some amyotrophic lateral sclerosis patients — plays a key role in the mechanism that…
Noxopharm and Nyrada Discover Potent Inhibitor of Key Protein Involved in ALS, Other Conditions
The pharmaceutical development company Noxopharm and its majority-owned subsidiary, U.S. biotechnology firm Nyrada, have discovered a potent inhibitor of…
A newly developed method can help characterize the types of misfolded proteins present in patients with amyotrophic lateral sclerosis…
A new process by which pro-death signaling is sent to nerve cells may hold the key for treating neurodegenerative diseases…
Systems Using Brain Signals to Communicate Can Help Advanced ALS Patients, But Improvements Needed
The Wadsworth Brain-Computer Interface (BCI) can help amyotrophic lateral sclerosis (ALS) patients who are severely disabled to communicate while in…
The Medicines and Healthcare products Regulatory Agency in the United Kingdom has granted permission to Tikomed to begin…
Treatment with extracts from the Withania somnifera plant improved motor performance and delayed disease progression in mice with amyotrophic lateral sclerosis (ALS), according to…
A newly developed test, known as the arrows and colors cognitive test, can be used to measure cognition in amyotrophic…
The first patient has been dosed in a Phase 3 clinical trial (NCT03491462) evaluating the effectiveness of Orphazyme’s…